Vladimír Rogalewicz

  • Citations Per Year
Learn More
At present, complex evaluation of medical devices is very topical. The methods of pharmacoeconomics and cost analyses appear to need some modifications caused by a different character of medical devices [1]. One of the approaches to this task is utilization of multi-criteria decision making [2]. In this study, a methodology for medical devices evaluation is(More)
Currently, the cross-border healthcare still represents a marginal part of the Czech healthcare system's performance, though. Compared to the total healthcare expenditures in the Czech Republic that accounted for CZK 299.9 billion in 2014, the costs of the treatment provided to Czech patients abroad constitute mere 0.27%, and the (subsequently refunded)(More)
BACKGROUND Hypothyroidism and/or autoimmune thyroid disorders (AITD) may contribute to spontaneous abortions (SpA). Cost-effectiveness analyses of thyroid screening in women after SpA are lacking. Our aim was to evaluate the cost-effectiveness of screening for AITD and/or hypothyroidism and their treatment in women after SpA with regard to their(More)
We developed a software package for management and evaluation of non-invasive cardiac autonomic tests. These tests aim to investigate the human cardiovascular function and its autonomic nervous control. Our system offers user-friendly features for managing patients and autonomic tests; for uploading measured cardiovascular signals and performing statistical(More)
Health Technology Assessment developed out of pharmacoeconomy; although it is routinely used for all health technologies incl. therapeutic interventions, preventive measures etc., its methodology fits best for drugs. Medical devices have their specificities that affect significantly all processess, where they are involved. The differences between medical(More)
reached CZK885,044 (~EUR32,260), with the Cardiohelp device (Maquet, Germany) CZK788,432 (~EUR28,738). The cost utility analysis revealed 3,961,970 CZK/QALY (~144,413 EUR/QALY) with Cardiohelp, and 4,447,457 CZK/QALY (~162,109 EUR/ QALY) when using Levitronix Centrimag. However, if only patients with CPC 1 were included into the analysis, the cost-utility(More)
Hospital-based HTA (HB-HTA) consists in implementation of assessment activities "in" or "for" hospitals; hence, it covers processes and methods supporting organization and execution of health technology assessment (HTA) at the level of individual hospitals. This process is multidisciplinary, systematic and evidence-based.HB-HTA objectives and methods differ(More)